These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 29447818

  • 1. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
    Czechowicz JA, Long-Boyle JR, Rosbe KW, Mathes EF, Frieden IJ, Shimano KA.
    Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
    [Abstract] [Full Text] [Related]

  • 2. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
    Dodds M, Tollefson M, Castelo-Soccio L, Garzon MC, Hogeling M, Hook K, Boull C, Maguiness S.
    Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
    [Abstract] [Full Text] [Related]

  • 3. Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.
    Yu L, Xu Z, Wei L, Zhang B, Qiu L, Ma L, Li L.
    Paediatr Drugs; 2024 May; 26(3):309-317. PubMed ID: 38280106
    [Abstract] [Full Text] [Related]

  • 4. Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.
    Grenier PO, McCormack L, Alshamekh SA, Adams DM, Trenor CC, O'Hare MJ, Liang MG.
    JAMA Dermatol; 2021 Feb 01; 157(2):233-235. PubMed ID: 33404600
    [Abstract] [Full Text] [Related]

  • 5. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
    Triana P, Miguel M, Díaz M, Cabrera M, López Gutiérrez JC.
    Lymphat Res Biol; 2019 Oct 01; 17(5):504-511. PubMed ID: 30985248
    [Abstract] [Full Text] [Related]

  • 6. Sirolimus for the treatment of complicated vascular anomalies in children.
    Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, Dasgupta R, Azizkhan RG, Adams DM.
    Pediatr Blood Cancer; 2011 Dec 01; 57(6):1018-24. PubMed ID: 21445948
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
    Le Sage S, David M, Dubois J, Powell J, McCuaig CC, Théorêt Y, Kleiber N.
    Pediatr Dermatol; 2018 Jul 01; 35(4):472-477. PubMed ID: 29790593
    [Abstract] [Full Text] [Related]

  • 8. Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.
    Badia P, Ricci K, Gurria JP, Dasgupta R, Patel M, Hammill A.
    Pediatr Blood Cancer; 2020 Apr 01; 67(4):e28088. PubMed ID: 31930696
    [Abstract] [Full Text] [Related]

  • 9. Topical sirolimus for treatment of a venolymphatic malformation in an adolescent girl.
    Cardis MA, DeKlotz CMC.
    Pediatr Dermatol; 2018 Nov 01; 35(6):e406-e407. PubMed ID: 30152558
    [Abstract] [Full Text] [Related]

  • 10. Sirolimus for the treatment of children with various complicated vascular anomalies.
    Lackner H, Karastaneva A, Schwinger W, Benesch M, Sovinz P, Seidel M, Sperl D, Lanz S, Haxhija E, Reiterer F, Sorantin E, Urban CE.
    Eur J Pediatr; 2015 Dec 01; 174(12):1579-84. PubMed ID: 26040705
    [Abstract] [Full Text] [Related]

  • 11. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
    Hammer J, Seront E, Duez S, Dupont S, Van Damme A, Schmitz S, Hoyoux C, Chopinet C, Clapuyt P, Hammer F, Vikkula M, Boon LM.
    Orphanet J Rare Dis; 2018 Oct 29; 13(1):191. PubMed ID: 30373605
    [Abstract] [Full Text] [Related]

  • 12. Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.
    Sandbank S, Molho-Pessach V, Farkas A, Barzilai A, Greenberger S.
    Acta Derm Venereol; 2019 Oct 01; 99(11):990-996. PubMed ID: 31304557
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
    Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M, Costa J, Ferreira J.
    J Vasc Surg; 2020 Jan 01; 71(1):318-327. PubMed ID: 31676179
    [Abstract] [Full Text] [Related]

  • 14. Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies.
    Mizuno T, Fukuda T, Emoto C, Mobberley-Schuman PS, Hammill AM, Adams DM, Vinks AA.
    Pediatr Blood Cancer; 2017 Aug 01; 64(8):. PubMed ID: 28205374
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P, Dore M, Cerezo VN, Cervantes M, Sánchez AV, Ferrero MM, González MD, Lopez-Gutierrez JC.
    Eur J Pediatr Surg; 2017 Feb 01; 27(1):86-90. PubMed ID: 27723921
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.
    Adams DM, Trenor CC, Hammill AM, Vinks AA, Patel MN, Chaudry G, Wentzel MS, Mobberley-Schuman PS, Campbell LM, Brookbank C, Gupta A, Chute C, Eile J, McKenna J, Merrow AC, Fei L, Hornung L, Seid M, Dasgupta AR, Dickie BH, Elluru RG, Lucky AW, Weiss B, Azizkhan RG.
    Pediatrics; 2016 Feb 01; 137(2):e20153257. PubMed ID: 26783326
    [Abstract] [Full Text] [Related]

  • 17. Single-center experience with sirolimus therapy for vascular malformations.
    Yesil S, Tanyildiz HG, Bozkurt C, Cakmakci E, Sahin G.
    Pediatr Hematol Oncol; 2016 Apr 01; 33(3):219-25. PubMed ID: 27128161
    [Abstract] [Full Text] [Related]

  • 18. Severe adverse events during sirolimus "off-label" therapy for vascular anomalies.
    Rössler J, Baselga E, Davila V, Celis V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM, Kapp FG.
    Pediatr Blood Cancer; 2021 Aug 01; 68(8):e28936. PubMed ID: 33580918
    [Abstract] [Full Text] [Related]

  • 19. No Association of Sirolimus with Wound Complications in Children With Vascular Anomalies.
    Mehl SC, Whitlock RS, Ortega RM, Creden S, Iacobas I, Maricevich RS, Rosenberg TL, Rialon KL.
    J Pediatr Surg; 2023 Aug 01; 58(8):1555-1559. PubMed ID: 36599792
    [Abstract] [Full Text] [Related]

  • 20. Effects of sirolimus in the treatment of unresectable infantile hemangioma and vascular malformations in children: A single-center experience.
    Cho YJ, Kwon H, Kwon YJ, Kim SC, Kim DY, Namgoong JM.
    J Vasc Surg Venous Lymphat Disord; 2021 Nov 01; 9(6):1488-1494. PubMed ID: 33836285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.